On ECHEMI
Home > Drugs > Liver cancer
Liver cancer
Liver cancer is the third most common malignant tumor with the highest mortality rate after gastric cancer and esophageal cancer. The early symptoms are not obvious, and the late stage mainly manifests as liver pain, fatigue, weight loss, jaundice, ascites and other symptoms. Clinically, Western medicine surgery, radiotherapy and chemotherapy combined with traditional Chinese medicine are generally used for treatment, but the cure rate of patients in the late stage is low due to the spread of cancer cells. Therefore, early detection, early diagnosis and early treatment of liver cancer are necessary. We should do a good job in liver cancer prevention and adhere to the seven-character liver cancer prevention policy of managing water, managing food and preventing hepatitis.
Related Drugs
Jinlong Capsule
Manufacturer:

Beijing Jiansheng Pharmaceutical Co., Ltd.

Gadopentetate Diglucamide Injection
Indication: MRI enhancement of the central nervous system and other parts. For normal brain tissue, there is no enhancement due to the presence of the blood-brain barrier; but the dura mater, choroid plexus, and pituitary gland may be enhanced. In addition to the central nervous system, other parts can also be applied. It can significantly increase the signal intensity of liver cancer and hepatic vascular cysts; distinguish liver cysts from normal liver tissue; diagnose or differentiate acute, subacute and chronic myocardial infarction, congenital heart disease, and dissecting aneurysms; it is also helpful for the diagnosis of nasopharyngeal carcinoma, breast cancer, and kidney tumors.
Manufacturer:

Beijing Beilu Pharmaceutical Co., Ltd.

Gadopentetate Diglucamide Injection
Indication: MRI enhancement of the central nervous system and other parts. For normal brain tissue, there is no enhancement due to the presence of the blood-brain barrier; but the dura mater, choroid plexus, and pituitary gland may be enhanced. In addition to the central nervous system, other parts can also be applied. It can significantly increase the signal intensity of liver cancer and hepatic vascular cysts; distinguish liver cysts from normal liver tissue; diagnose or differentiate acute, subacute and chronic myocardial infarction, congenital heart disease, and dissecting aneurysms; it is also helpful for the diagnosis of nasopharyngeal carcinoma, breast cancer, and kidney tumors.
Manufacturer:

Beijing Beilu Pharmaceutical Co., Ltd.

Gadopentetate Diglucamide Injection
Indication: MRI enhancement of the central nervous system and other parts. For normal brain tissue, there is no enhancement due to the presence of the blood-brain barrier; but the dura mater, choroid plexus, and pituitary gland may be enhanced. In addition to the central nervous system, other parts can also be applied. It can significantly increase the signal intensity of liver cancer and hepatic vascular cysts; distinguish liver cysts from normal liver tissue; diagnose or differentiate acute, subacute and chronic myocardial infarction, congenital heart disease, and dissecting aneurysms; it is also helpful for the diagnosis of nasopharyngeal carcinoma, breast cancer, and kidney tumors.
Manufacturer:

Guangzhou Consun Pharmaceutical Co., Ltd.

Gadobenate dimeglumine injection
Indication: Gadobenate dimeglumine is a paramagnetic contrast agent indicated for diagnostic magnetic resonance imaging (MRI) of the liver and central nervous system. Liver: Indicated for the detection of focal liver lesions in patients with known or suspected primary liver cancer (e.g., hepatocellular carcinoma) or metastatic cancer. Central nervous system: Gadobenate dimeglumine is also indicated for enhanced MRI of the brain and spine, where it can enhance the detection of lesions and provide more diagnostic information than unenhanced MRI images.
Gadobenate dimeglumine injection
Indication: Gadobenate dimeglumine is a paramagnetic contrast agent indicated for diagnostic magnetic resonance imaging (MRI) of the liver and central nervous system. Liver: Indicated for the detection of focal liver lesions in patients with known or suspected primary liver cancer (e.g., hepatocellular carcinoma) or metastatic cancer. Central nervous system: Gadobenate dimeglumine is also indicated for enhanced MRI of the brain and spine, which can enhance the detection of lesions and provide more diagnostic information than unenhanced MRI images.
Methotrexate
Indication: 1. Systemic medication for the treatment of choriocarcinoma, malignant hydatidiform mole, various acute leukemias with breast cancer, lung cancer, head and neck cancer, digestive tract cancer, cervical cancer and malignant lymphoma. 2. Arterial catheter perfusion has a good effect on head and neck cancer and liver cancer. 3. High-dose methotrexate supplemented with calcium folinate rescue (HDMTX-CFR therapy) has a certain effect as postoperative adjuvant chemotherapy or systemic treatment of advanced lesions for osteosarcoma, soft tissue sarcoma, malignant lymphoma, acute lymphocytic leukemia with breast cancer, ovarian cancer, small cell lung cancer, etc.
Methotrexate
Indication: 1. Systemic medication for the treatment of choriocarcinoma, malignant hydatidiform mole, various acute leukemias with breast cancer, lung cancer, head and neck cancer, digestive tract cancer, cervical cancer and malignant lymphoma. 2. Arterial catheter perfusion has a good effect on head and neck cancer and liver cancer. 3. High-dose methotrexate supplemented with calcium folinate rescue (HDMTX-CFR therapy) has a certain effect as postoperative adjuvant chemotherapy or systemic treatment of advanced lesions for osteosarcoma, soft tissue sarcoma, malignant lymphoma, acute lymphocytic leukemia with breast cancer, ovarian cancer, small cell lung cancer, etc.
Manufacturer:

Bei Jing Scrianen Pharmaceutical Co., Ltd.

Methotrexate
Indication: 1. Systemic medication for the treatment of choriocarcinoma, malignant hydatidiform mole, various acute leukemias with breast cancer, lung cancer, head and neck cancer, digestive tract cancer, cervical cancer and malignant lymphoma. 2. Arterial catheter perfusion has a good effect on head and neck cancer and liver cancer. 3. High-dose methotrexate supplemented with calcium folinate rescue (HDMTX-CFR therapy) has a certain effect as postoperative adjuvant chemotherapy or systemic treatment of advanced lesions for osteosarcoma, soft tissue sarcoma, malignant lymphoma, acute lymphocytic leukemia with breast cancer, ovarian cancer, small cell lung cancer, etc.
Manufacturer:

Zhejiang Hisun Pharmaceutical Co., Ltd.

Methotrexate
Indication: 1. Systemic medication for the treatment of choriocarcinoma, malignant hydatidiform mole, various acute leukemias with breast cancer, lung cancer, head and neck cancer, digestive tract cancer, cervical cancer and malignant lymphoma. 2. Arterial catheter perfusion has a good effect on head and neck cancer and liver cancer. 3. High-dose methotrexate supplemented with calcium folinate rescue (HDMTX-CFR therapy) has a certain effect as postoperative adjuvant chemotherapy or systemic treatment of advanced lesions for osteosarcoma, soft tissue sarcoma, malignant lymphoma, acute lymphocytic leukemia with breast cancer, ovarian cancer, small cell lung cancer, etc.
Manufacturer:

Huzhou Zhanwang Pharmaceutical Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.